Perspective Therapeutics (CATX) Institutional Ownership → Bill Gates is all about this tiny $2 stock (From Timothy Sykes) (Ad) Free CATX Stock Alerts $1.38 +0.06 (+4.55%) (As of 05/31/2024 08:50 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Perspective Therapeutics (NYSE:CATX)CurrentInstitutional OwnershipPercentage54.66%Number ofInstitutional Buyers(last 12 months)13Number ofInstitutional Sellers(last 12 months)2 Get CATX Insider Trade Alerts Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CATX Institutional Buying and Selling by Quarter Ad Weiss RatingsNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. Perspective Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC115,762$138K0.0%N/A0.019% 5/16/2024 Janus Henderson Group PLC13,089,476$15.51M0.0%N/A2.230% 5/15/2024 Baker BROS. Advisors LP149,787$178K0.0%-98.0%0.026% 5/15/2024 Affinity Asset Advisors LLC5,100,000$6.07M0.8%N/A0.869% 5/10/2024 Vanguard Group Inc.17,780,106$21.16M0.0%+34.6%3.029% 5/8/2024 Bleakley Financial Group LLC33,570$40K0.0%N/A0.006% 5/3/2024 RIA Advisory Group LLC106,853$127K0.1%+1,313.4%0.018% 4/26/2024 ZWJ Investment Counsel Inc.22,000$26K0.0%N/A0.004% 4/24/2024 Simplicity Wealth LLC33,570$40K0.0%N/A0.006% 1/22/2024 Perkins Capital Management Inc.700,000$281K0.2%-73.8%0.249% 1/11/2024 Taylor & Morgan Wealth Management LLC625,000$251K0.2%+8.7%0.223% 11/8/2023 HighTower Advisors LLC1,147,038$314K0.0%N/A0.409% 11/2/2023 Perkins Capital Management Inc.2,671,644$731K0.7%N/A0.952% 10/24/2023 Bank of New York Mellon Corp154,238$42K0.0%N/A0.055% 10/16/2023 Wealth Effects LLC110,000$30K0.0%N/A0.039% 10/5/2023 Taylor & Morgan Wealth Management LLC575,000$157K0.1%N/A0.205% (Data available from 1/1/2016 forward) CATX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CATX shares? During the previous two years, 14 institutional investors and hedge funds held shares of Perspective Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($21.16M), Janus Henderson Group PLC ($15.51M), Affinity Asset Advisors LLC ($6.07M), HighTower Advisors LLC ($314K), Perkins Capital Management Inc. ($281K), Taylor & Morgan Wealth Management LLC ($251K), and Baker BROS. Advisors LP ($178K).Learn more on CATX's institutional investors. What percentage of Perspective Therapeutics stock is owned by institutional investors? 54.66% of Perspective Therapeutics stock is owned by institutional investors. Learn more on CATX's institutional investor holdings. Which institutional investors have been buying Perspective Therapeutics stock? Of the 13 institutional investors that purchased Perspective Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Janus Henderson Group PLC ($13.09M), Affinity Asset Advisors LLC ($5.10M), Vanguard Group Inc. ($4.57M), Perkins Capital Management Inc. ($2.67M), HighTower Advisors LLC ($1.15M), Taylor & Morgan Wealth Management LLC ($625K), and Bank of New York Mellon Corp ($154.24K). How much institutional buying is happening at Perspective Therapeutics? Institutional investors have bought a total of 27,767,947 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Which Perspective Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Perspective Therapeutics stock in the last 24 months: Baker BROS. Advisors LP ($7.49M), and Perkins Capital Management Inc. ($1.97M). How much institutional selling is happening at Perspective Therapeutics? Institutional investors have sold a total of 9,461,560 shares in the last 24 months. This volume of shares sold represents approximately $0.00 in transactions. Related Companies: AXNX Major Shareholders PRCT Major Shareholders TNDM Major Shareholders NARI Major Shareholders IRTC Major Shareholders ICUI Major Shareholders IART Major Shareholders NVCR Major Shareholders UFPT Major Shareholders LMAT Major Shareholders This page (NYSE:CATX) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
